From the Department of Pediatrics, Seoul Metropolitan Government-Seoul National University Boramae Medical Center.
Department of Pediatrics, Seoul National University College of Medicine, Seoul.
Pediatr Infect Dis J. 2023 May 1;42(5):423-428. doi: 10.1097/INF.0000000000003872. Epub 2023 Feb 14.
The SARS-CoV-2 variants of concern exhibit distinct features in terms of transmissibility and virulence. This study compared the clinical characteristics of COVID-19 in children during pre-Delta, Delta and Omicron waves.
Medical records of 1163 children <19 years of age with COVID-19 admitted to a designated hospital in Seoul, South Korea, were analyzed. Clinical and laboratory findings during the pre-Delta (March 1, 2020, to June 30, 2021; 330 children), Delta (July 1, 2021, to December 31, 2021; 527 children) and Omicron (January 1, 2022, to May 10, 2022; 306 children) waves were compared.
Children during the Delta wave were older and had a higher proportion of fever ≥5 days and pneumonia than children during the pre-Delta and Omicron waves. The Omicron wave was characterized by younger age and a higher proportion of fever ≥39.0 °C, febrile seizure and croup. More children <2 years of age and adolescents aged 10 to <19 years experienced neutropenia and lymphopenia, respectively, during the Delta wave. Children aged 2 to <10 years had a higher incidence of leukopenia and lymphopenia during the Omicron wave.
Distinct features of COVID-19 were observed in children during the Delta and Omicron surges. Continuous scrutiny of the manifestations of variants of concern is needed for appropriate public health response and management.
引起关注的 SARS-CoV-2 变体在传染性和毒力方面表现出不同的特征。本研究比较了德尔塔和奥密克戎变异株流行期间儿童 COVID-19 的临床特征。
分析了韩国首尔一家指定医院收治的 1163 名<19 岁的 COVID-19 患儿的病历。比较了德尔塔(2021 年 7 月 1 日至 2021 年 12 月 31 日;527 例)和奥密克戎(2022 年 1 月 1 日至 2022 年 5 月 10 日;306 例)流行期间的临床和实验室发现。
与前德尔塔和奥密克戎波相比,德尔塔波的儿童年龄较大,发热≥5 天和肺炎的比例较高。奥密克戎波的特点是年龄较小,发热≥39.0°C、热性惊厥和喉炎的比例较高。更多<2 岁和 10 至<19 岁的青少年在德尔塔波期间出现中性粒细胞减少和淋巴细胞减少。2 至<10 岁的儿童在奥密克戎波期间白细胞减少和淋巴细胞减少的发生率较高。
在德尔塔和奥密克戎流行期间,儿童 COVID-19 的表现存在明显特征。需要持续关注关注变异株的表现,以便做出适当的公共卫生应对和管理。